Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sturm, Ekkehard
BOLD, NCT04336722 / 2019-003807-37: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE	Active, not recruiting	3	254	Europe, Canada, US, RoW	Odevixibat, Placebo	Albireo, an Ipsen Company	Biliary Atresia	06/26	07/26
Bufler, Philip
BOLD, NCT04336722 / 2019-003807-37: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE	Active, not recruiting	3	254	Europe, Canada, US, RoW	Odevixibat, Placebo	Albireo, an Ipsen Company	Biliary Atresia	06/26	07/26
Reinshagen, Konrad
BOLD, NCT04336722 / 2019-003807-37: Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE	Active, not recruiting	3	254	Europe, Canada, US, RoW	Odevixibat, Placebo	Albireo, an Ipsen Company	Biliary Atresia	06/26	07/26